Recent Finacing
Recent Raise
Synthonics discovers, develops and licenses patent‑protected metal‑coordinated pharmaceuticals using proprietary metal‑coordination chemistry and delivery technology to modify pharmacokinetics, absorption, toxicity, dosing, release, and targeted delivery, partnering with contract manufacturers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor